274 related articles for article (PubMed ID: 19714744)
1. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
[TBL] [Abstract][Full Text] [Related]
2. Common PPARγ variants C161T and Pro12Ala are not associated with inflammatory bowel disease in an Australian cohort.
Hume GE; Fowler EV; Griffiths LR; Doecke JD; Radford-Smith GL
J Gastrointestin Liver Dis; 2012 Dec; 21(4):349-55. PubMed ID: 23256116
[TBL] [Abstract][Full Text] [Related]
3. Association between the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 and inflammatory bowel disease: a meta-analysis.
Zhang ZF; Yang N; Zhao G; Zhu L; Wang LX
PLoS One; 2012; 7(1):e30551. PubMed ID: 22276212
[TBL] [Abstract][Full Text] [Related]
4. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.
Dongxia L; Qi H; Lisong L; Jincheng G
Circ J; 2008 Apr; 72(4):551-7. PubMed ID: 18362424
[TBL] [Abstract][Full Text] [Related]
5. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease.
Atug O; Tahan V; Eren F; Tiftikci A; Imeryuz N; Hamzaoglu HO; Tozun N
J Gastrointestin Liver Dis; 2008 Dec; 17(4):433-7. PubMed ID: 19104705
[TBL] [Abstract][Full Text] [Related]
6. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort.
Poliska S; Penyige A; Lakatos PL; ; Papp M; Palatka K; Lakatos L; Molnar T; Nagy L
Inflamm Bowel Dis; 2012 Mar; 18(3):472-9. PubMed ID: 21710534
[TBL] [Abstract][Full Text] [Related]
7. Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients.
Chao CT; Chen YC; Chiang CK; Huang JW; Fang CC; Chang CC; Yen CJ
Oxid Med Cell Longev; 2016; 2016():8516748. PubMed ID: 26881045
[TBL] [Abstract][Full Text] [Related]
8. CTLA4 gene polymorphisms in Dutch and Chinese patients with inflammatory bowel disease.
Xia B; Crusius JB; Wu J; Zwiers A; van Bodegraven AA; Peña AS
Scand J Gastroenterol; 2002 Nov; 37(11):1296-300. PubMed ID: 12465728
[TBL] [Abstract][Full Text] [Related]
9. Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients.
Liu F; Mei X; Zhang Y; Qi H; Wang J; Wang Y; Jiang W; Zhang X; Yan H; Zhuang S
Mol Biol Rep; 2014 Nov; 41(11):7555-65. PubMed ID: 25096510
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.
Falvey JD; Bentley RW; Merriman TR; Hampton MB; Barclay ML; Gearry RB; Roberts RL
World J Gastroenterol; 2013 Oct; 19(39):6656-64. PubMed ID: 24151396
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.
Andersen V; Christensen J; Ernst A; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
World J Gastroenterol; 2011 Jan; 17(2):197-206. PubMed ID: 21245992
[TBL] [Abstract][Full Text] [Related]
12. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.
Jiang J; Gajalakshmi V; Wang J; Kuriki K; Suzuki S; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
Cancer Sci; 2005 Aug; 96(8):507-12. PubMed ID: 16108832
[TBL] [Abstract][Full Text] [Related]
13. The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S; Liu L; Zhuge QC; Yu Z; Zhang X; Xie J; Hong W; Wang S; Yang Y; Chen B
Wien Klin Wochenschr; 2012 Oct; 124(19-20):671-7. PubMed ID: 22987045
[TBL] [Abstract][Full Text] [Related]
14. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S; Chamaie-Nejad F; Ebrahimi A; Najafi F; Rahimi Z; Vaisi-Raygani A; Shakiba E; Rahimi Z
Adv Med Sci; 2018 Mar; 63(1):147-151. PubMed ID: 29120856
[TBL] [Abstract][Full Text] [Related]
15. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
[TBL] [Abstract][Full Text] [Related]
16. Genetic characteristics of inflammatory bowel disease in a Japanese population.
Fuyuno Y; Yamazaki K; Takahashi A; Esaki M; Kawaguchi T; Takazoe M; Matsumoto T; Matsui T; Tanaka H; Motoya S; Suzuki Y; Kiyohara Y; Kitazono T; Kubo M
J Gastroenterol; 2016 Jul; 51(7):672-81. PubMed ID: 26511940
[TBL] [Abstract][Full Text] [Related]
17. Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India.
Bhatt SP; Nigam P; Misra A; Guleria R; Luthra K; Pandey RM; Pasha MA
Gene; 2013 Jan; 512(1):143-7. PubMed ID: 23031808
[TBL] [Abstract][Full Text] [Related]
18. [Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations].
Shen XY; Shi RH; Wang Y; Zhang HJ; Zhou XQ; Shen FC; Li KB
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1416-20. PubMed ID: 20646633
[TBL] [Abstract][Full Text] [Related]
19. Association of Fucosyltransferase 2 Gene Variant with Inflammatory Bowel Diseases: A Meta-Analysis.
Zhou F; Zhu Q; Zheng PF; Feng YL
Med Sci Monit; 2019 Jan; 25():184-192. PubMed ID: 30615603
[TBL] [Abstract][Full Text] [Related]
20. Candidate polymorphisms and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.
Tang L; Xu M
Gene; 2020 Aug; 753():144814. PubMed ID: 32464244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
